文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

孟加拉国南部奥密克戎变异株流行期间成人对COVID-19加强针疫苗信心的潜在预测因素:一项横断面分析

Potential predictors of COVID-19 booster vaccine confidence among adult people: a cross-sectional analysis amid the Omicron surge in Southern Bangladesh.
PubMed 文献 · Vaccine · 2025-09-05

该研究于2023年6月15日至8月31日奥密克戎变异株流行期间在孟加拉国南部对18-49岁成人进行面对面横断面调查,评估COVID-19加强针疫苗信心(CBVC)及其潜在预测因素。合并CBVC为74.3%(95%CI 71.1-77.6%)。多因素分析中「同等安全」和「信任」与CBVC呈高度显著正相关(aOR分别为2.164和2.054),「有效性」和「社会关怀」也呈显著正相关(aOR分别为1.051和1.209);女性对保护他人责任感更强但更担心副作用,年轻和低教育水平与较低信心和信任相关。

要点

  • 成人COVID-19加强针疫苗信心合并为74.3%(95%CI 71.1-77.6%)。
  • 「同等安全」和「信任」与加强针信心呈高度显著正相关(aOR为2.164和2.054)。
  • 年轻和低教育水平与加强针疫苗信心及信任水平较低相关。

核心结论

  • 本研究报道COVID-19加强针疫苗信心较高,但加强针信心存在明显的人口学和心理学差异。
  • 作者认为,提供来自可靠来源的准确、最新信息以及关于疫苗安全性和有效性的教育,可能改善边缘化人群的CBVC覆盖率。

研究设计与样本

  • 遵循STROBE指南的面对面横断面调查,于2023年6月15日至8月31日SARS-CoV-2奥密克戎变异株传播期间开展。
  • 研究对象为孟加拉国18-49岁成人。
  • 采用单因素方差分析、独立样本t检验和二元逻辑回归评估与CBVC相关的潜在因素。

主要发现

  • 成人调查中合并COVID-19加强针疫苗信心为74.3%(95%CI 71.1-77.6%)。
  • 多数参与者确信加强针对新SARS-CoV-2变异株安全(64.9%)和有效(53.8%),74.0%表示信任疫苗接种服务。
  • 在10个潜在因素中,「同等安全」和「信任」与CBVC呈高度显著正相关(aOR分别为2.164和2.054)。
  • 二元分析还显示「有效性」和「社会关怀」与CBVC呈显著正相关(aOR分别为1.051和1.209)。
  • t检验分析中,女性对接种加强针以保护他人感到更有责任(t=-4.21,P=0.001),但也更担心不必要的副作用(t=-4.79,P=0.001)。

临床怎么用

  • 作者认为,提供来自可靠来源的准确、最新信息以及关于疫苗安全性和有效性的教育,可能改善边缘化人群的CBVC覆盖率。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite the therapeutic potential of the primary vaccine series, a lack of confidence in the COVID-19 booster vaccine poses a threat to public health and undermines its coverage at the national, regional, and global levels. This study aimed to understand COVID-19 booster vaccine confidence (CBVC) among Bangladeshi adults aged 18-49 and the potential predictors of CBVC. In line with STROBE guidelines, a face-to-face cross-sectional survey was conducted from June 15 to August 31, 2023 during the spread of the SARS-CoV-2 Omicron variant. A one-way ANOVA analysis, independent-sample t-test, and binary logistic regression were employed to assess the potential antecedents associated with CBVC. The pooled COVID-19 booster vaccine confidence was 74.3 % (95 % CI, 71.1-77.6 %) among adult polls. Majority of participants were confident that booster vaccinations are safe (64.9 %) and effective (53.8 %) against new SARS-CoV-2 variants, with 74.0 % stating that they were trusted by vaccination services. Out of the ten potential factors, "equal safety" and "trust" had a highly significant positive association with CBVC ([aOR]: 2.164 and [aOR]: 2.054, respectively). Binary analysis also revealed that "effectiveness" and "social care" had a significant positive association with CBVC ([aOR]: 1.051 and [aOR]: 1.209, respectively). In the t-test analysis, females felt more responsible for getting the booster vaccine to protect others (t = -4.21, P = 0.001), however, they also worried about unwanted side effects (t = -4.79, P = 0.001). The post-hoc comparison found that being younger and having a lower education was associated with a lower level of confidence in booster vaccines and trust. This study reported high confidence in the COVID-19 booster vaccine, but there were noticeable demographic and psychological differences in booster confidence. The provision of accurate, up-to-date information from reliable sources, as well as education about the safety and efficacy of vaccines might improve CBVC coverage among marginalized populations.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Roy DN, Rashid M, Aktar A, et al. Potential predictors of COVID-19 booster vaccine confidence among adult people: a cross-sectional analysis amid the Omicron surge in Southern Bangladesh. Vaccine. 2025. PMID: 40913815. doi:10.1016/j.vaccine.2025.127693

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。